26 Polen Capital Novo Nordisk Trades
Polen Capital acquired 6.41 Million Novo Nordisk shares worth $421 Million. That's 1.19% of their equity portfolio (23rd largest holding). The first Novo Nordisk trade was made in Q2 2013. Since then Polen Capital bought shares eighteen more times and sold shares on seven occasions. The investor's estimated purchase price is $1.05 Billion, resulting in a loss of 60%.
News about Novo Nordisk - ADR and Polen Capital
Novo Nordisk A/S (NVO) Q2 2024 Earnings Call Transcript
Novo Nordisk A/S (NVO) Q2 2024 Earnings Conference Call August 7, 2024 7:00 AM ET Company Participants Jacob Martin Wiborg Rode - Head of Investor Relations ...
KKR, Novo Nordisk, others bid for Healthium buy
Global PE major KKR and pharma major Novo Nordisk have submitted final bids for Healthium. A third, joint bid has come from India-focused PE firm ChrysCapita...
BMO Capital starts Novo Nordisk at Outperform
https://www.investing.com/news/stock-market-news/bmo-capital-starts-novo-nordisk-at-outperform-432SI-3376910
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
WHY: NEW YORK, NY - ( NewMediaWire ) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...